Posts by ericg
Fiandaca steps down as transportation secretary after only months on the job
After only months on the job, Transportation Secretary Gina Fiandaca plans to step down in two weeks and hand the role of the Healey administration’s top transportation official to a deputy, Gov. Maura Healey’s office announced Monday. Read More
Read MoreCVS Health to lay off 140 Massachusetts employees
Over 100 employees in Boston and Wellesley will be let go in October. Read More
Read MoreLocal tech executive’s loss inspired him to paint “The Giant Boob Cow” to benefit Dana-Farber
Richard Banfield, the founder and CEO of Fresh Tilled Soil, lost his wife Kristy to cancer in 2022. He sold his company and turned to art as a form of solace to grieve her passing. Read More
Read MoreFive things you need to know, and welcoming new Bostonians
Here are the five things you need to know today. Read More
Read MoreMastercard’s cannabis ban makes industry less safe, say entrepreneurs
Dispensary owners say Mastercard’s ban on cannabis debit transactions will lead to a greater reliance on cash. Read More
Read MoreHere’s what happened in higher ed during your summer vacation
The Supreme Court overturning affirmative action in university admissions processes was not the only news as the new school year begins. Read More
Read MoreTop court sides against Robinhood, upholds Mass. fiduciary duty rule
The state Supreme Judiciary Court ruled against online brokerage Robinhood in its fight to block a Massachusetts fiduciary rule that says that broker-dealers have a fiduciary obligation to provide investment advice without regard to the interests of anyone but their customers. Read More
Read MoreLabor unions get another leg up from the NLRB in unionization battle
The new rule from the National Labor Relations Board is the latest effort by the Biden Administration to remove barriers to union organizing. Read More
Read MoreKlaviyo files for IPO in a first for 2023
Klaviyo is the first major tech company based in the Bay State to file for an IPO in a year when economic uncertainty has kept many firms away from the public markets. Read More
Read MoreNovartis comes for a Biogen MS drug with new biosimilar
On Thursday, the U.S. Food and Drug Administration approved a new biosimilar designed to mimic Tysabri, one of Biogen’s (Nasdaq: BIIB) MS products. Biosimilars, like generics, are typically more affordable versions of brand-name drugs. Read More
Read More